FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle

Business by 2FIRSTS, edited by Sophia
Mar.05.2024
FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
Philippine Customs seized unregistered, unauthorized e-cigarette products worth 4 billion pesos, impacting Chinese brands like Romio and OXVA.

On the evening of February 29th, the Philippine Bureau of Customs Intelligence and Investigation Services seized a shipment of e-cigarette products valued at 4 billion pesos (approximately 510 million RMB, 70 billion USD) that were not registered in the Philippines and lacked the necessary authorization certificates. The confiscated FLAVA vape products are believed to have originated from the Philippines. (Read more: Breaking: Philippines Authorities Seize $70 Million's Flava Products)

 

Against this backdrop, 2FIRSTS had discussions with several individuals who are familiar with the e-cigarette market in the Philippines to understand the current situation of the market.

 

FLAVA is the leading distribution brand in the Philippines. It is understood that the Philippines has three major distribution companies, namely FLAVA, DENKAT, and SHIFT. Any brand looking to enter the Philippine market through these channels needs to establish a co-branding partnership with them. For example, the e-cigarette brand OXBAR (from OXVA) sold in the Philippines market carries the FLAVA brand logo on its product packaging and promotional materials.

 

FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
OXBAR products sold in the Philippines market come with the FLAVA logo | Image source: OXBAR

 

According to sources, the recent seizure of goods by FLAVA has had a significant impact on the Chinese companies they were working with. FLAVA did not fully pay for the goods they were purchasing, with some orders only paying 30% to 50%, and even as low as 20%. 

 

According to sources familiar with the e-cigarette market in the Philippines, Romio (from Shenzhen Maoanda Technology Co., Ltd. according to QCC) and OXVA (from Shenzhen Future Tech CO., Limited according to QCC), which have the closest cooperation with FLAVA, are considered the two Chinese brands most affected by this event. Among the products released on FLAVA's official social media platforms, Romio and OXBAR, a brand under OXVA, are the two brands with the highest frequency of appearance.

 

FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
Romio products in collaboration with FLAVA | Image source: Filipino distribution website

 

Judging from FLAVA's social media account, the brands that are also associated with them include GEEK BAR, FLONQ, and NIMMBOX.

 

FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
Image source: FLAVA social media account

 

Sources revealed that the e-cigarette market in the Philippines is currently in a state of extreme chaos. Some brands planning to enter the market are feeling uneasy, as they are facing difficulties in collecting payments from distributors, who are refusing their requests. 

 

Furthermore, with FLAVA experiencing heavy losses, the e-cigarette market in the Philippines is currently undergoing a period of restructuring. Distributor SHIFT is seizing this opportunity to aggressively expand its channel business and has launched a promotion offering a free motorcycle with the purchase of an e-cigarette. As a result, many industry insiders speculate that after FLAVA's decline, SHIFT could become the "new king." According to insiders, SHIFT was founded by Filipino real estate and casino businessmen, with strong backing.

 

2FIRSTS will continue to monitor the dynamics of the e-cigarette market in the Philippines and will provide updates on the 2FIRSTS mobile app and www.2firsts.com in a timely manner. Stay tuned for more information.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia’s tobacco excise debate is increasingly exposing differences within the governing Labor Party. New South Wales Labor Premier Chris Minns reaffirmed on September 8 that he supports reducing tobacco excise, arguing that current tax settings are pushing consumers toward cheaper black-market cigarettes. Federal Health Minister Mark Butler continues to oppose an excise cut, while Treasurer Jim Chalmers and Assistant Treasurer Daniel Mulino have recently stopped short of ruling out future changes. The divergence follows the opposition Coalition’s proposal to cut tobacco excise by 80%.
Sep.08
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
At the 2026 NACS Show in Las Vegas, JTI Liggett highlighted its value-priced cigarette portfolio, including LD and Montego, following JT Group's acquisition of Vector Group. The company's U.S. business reported market share gains, with LD sales volume rising 32.6% in the first half of 2026. Meanwhile, Ploom was displayed separately at Altria's booth under an existing partnership. JTI Liggett booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States.
EXPO
Oct.09